Ana Campos Codo

Ana Campos Codo

Auto-generated profile, based on publicly available information

Ana Campos Codo

Immunology Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2020 in Cell Metabolism
Verified
Journal Article
Closed access
ACAna Campos Codo
Ana Campos Codo
GDGustavo Gastão Davanzo
Gustavo Gastão Davanzo
LMLauar de Brito Monteiro
Lauar de Brito Monteiro
GSGabriela Fabiano de Souza
Gabriela Fabiano de Souza
SMStéfanie Primon Muraro
Stéfanie Primon Muraro
Pedro M Moraes-VieiraPedro M Moraes-Vieira
Pedro M Moraes-Vieira

11 August 2022 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
FCFernanda Crunfli
Fernanda Crunfli
VCVictor Carregari
Victor Carregari
FVFlavio P. Veras
Flavio P. Veras
LSLucas S. Silva
Lucas S. Silva
MNMateus Henrique Nogueira
Mateus Henrique Nogueira
DMDaniel Martins-de-Souza
Daniel Martins-de-Souza
Although increasing evidence confirms neuropsychiatric manifestations associated mainly with severe COVID-19 infection, long-term neuropsychiatric dysfunction (recently characterized as part of “long COVID-19” syndrome) has been frequently observed after mild infection. We show the spectrum of cerebral impact of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, ranging from long-term alterations in mildly infected individuals (orbitofrontal cortical atrophy, neurocognitive impairment, excessive fatigue and anxiety symptoms) to severe acute damage confirmed in brain tissue samples extracted from the orbitofrontal region (via endonasal transethmoidal access) from individuals who died of COVID-19. In an independent cohort of 26 individuals who died of COVID-19, we used histopathological signs of brain damage as a guide for possible SARS-CoV-2 brain infection and found that among the 5 individuals who exhibited those signs, all of them had genetic material of the virus in the brain. Brain tissue samples from these five patients also exhibited foci of SARS-CoV-2 infection and replication, particularly in astrocytes. Supporting the hypothesis of astrocyte infection, neural stem cell–derived human astrocytes in vitro are susceptible to SARS-CoV-2 infection through a noncanonical mechanism that involves spike–NRP1 interaction. SARS-CoV-2–infected astrocytes manifested changes in energy metabolism and in key proteins and metabolites used to fuel neurons, as well as in the biogenesis of neurotransmitters. Moreover, human astrocyte infection elicits a secretory phenotype that reduces neuronal viability. Our data support the model in which SARS-CoV-2 reaches the brain, infects astrocytes, and consequently, leads to neuronal death or dysfunction. These deregulated processes could contribute to the structural and functional alterations seen in the brains of COVID-19 patients.

13 October 2020 in medRxiv
Verified
Preprint
Open access
PDF file
FCFernanda Crunfli
Fernanda Crunfli
VCVictor Carregari
Victor Carregari
FVFlavio Protasio Veras
Flavio Protasio Veras
PVPedro Henrique Vendramini
Pedro Henrique Vendramini
AVAline Gazzola Fragnani Valença
Aline Gazzola Fragnani Valença
MSMaria Ercilia de Paula Castilho Stefano
Maria Ercilia de Paula Castilho Stefano
Although increasing evidence confirms neuropsychiatric manifestations associated mainly with severe COVID-19 infection, the long-term neuropsychiatric dysfunction has been frequently observed after mild infection. Here we show the spectrum of the cerebral impact of SARS-CoV-2 infection ranging from long-term alterations in mildly infected individuals (orbitofrontal cortical atrophy, neurocognitive impairment, excessive fatigue and anxiety symptoms) to severe acute damage confirmed in brain tissue samples extracted from the orbitofrontal region (via endonasal trans-ethmoidal approach) from individuals who died of COVID-19. We used surface-based analyses of 3T MRI and identified orbitofrontal cortical atrophy in a group of 81 mildly infected patients (77% referred anosmia or dysgeusia during acute stage) compared to 145 healthy volunteers; this atrophy correlated with symptoms of anxiety and cognitive dysfunction. In an independent cohort of 26 individuals who died of COVID-19, we used histopathological signs of brain damage as a guide for possible SARS-CoV-2 brain infection, and found that among the 5 individuals who exhibited those signs, all of them had genetic material of the virus in the brain. Brain tissue samples from these 5 patients also exhibited foci of SARS-CoV-2 infection and replication, particularly in astrocytes. Supporting the hypothesis of astrocyte infection, neural stem cell-derived human astrocytes in vitro are susceptible to SARS-CoV-2 infection through a non-canonical mechanism that involves spike-NRP1 interaction. SARS-CoV-2-infected astrocytes manifested changes in energy metabolism and in key proteins and metabolites used to fuel neurons, as well as in the biogenesis of neurotransmitters. Moreover, human astrocyte infection elicits a secretory phenotype that reduces neuronal viability. Our data support the model in which SARS-CoV-2 reaches the brain, infects astrocytes and consequently leads to neuronal death or dysfunction. These deregulated processes are also likely to contribute to the structural and functional alterations seen in the brains of COVID-19 patients.

5 December 2018 in Cell Death & Disease
Verified
Journal Article
Open access
PDF file
ACAna Campos Codo
Ana Campos Codo
ASAmanda Correia Saraiva
Amanda Correia Saraiva
LSLeonardo Lima dos Santos
Leonardo Lima dos Santos
MVMarina Francisco Visconde
Marina Francisco Visconde
AGAna Cristina Gales
Ana Cristina Gales
AMAlexandra Ivo Medeiros
Alexandra Ivo Medeiros
Klebsiella pneumoniae is a Gram-negative bacterium responsible for severe cases of nosocomial pneumonia. During the infectious process, both neutrophils and monocytes migrate to the site of infection, where they carry out their effector functions and can be affected by different patterns of cell death. Our data show that clinical strains of K. pneumoniae have dissimilar mechanisms for surviving within macrophages; these mechanisms include modulation of microbicidal mediators and cell death. The A28006 strain induced high IL-1β production and pyroptotic cell death in macrophages; by contrast, the A54970 strain induced high IL-10 production and low IL-1β production by macrophages. Pyroptotic cell death induced by the A28006 strain leads to a significant increase in bacterial sensitivity to hydrogen peroxide, and efferocytosis of the pyroptotic cells results in efficient bacterial clearance both in vitro and in vivo. In addition, the A54970 strain was able to inhibit inflammasome activation and pyroptotic cell death by inducing IL-10 production. Here, for the first time, we present a K. pneumoniae strain able to inhibit inflammasome activation, leading to bacterial survival and dissemination in the host. The understanding of possible escape mechanisms is essential in the search for alternative treatments against multidrug-resistant bacteria.

1 May 2020 in Immunobiology
Verified
Journal Article
Closed access
LMLauar de Brito Monteiro
Lauar de Brito Monteiro
GDGustavo Gastão Davanzo
Gustavo Gastão Davanzo
Cristhiane Favero AguiarCristhiane Favero Aguiar
Cristhiane Favero Aguiar
FSFelipe Corrêa da Silva
Felipe Corrêa da Silva
JAJessica Rodrigues de Andrade
Jessica Rodrigues de Andrade
Pedro M Moraes-VieiraPedro M Moraes-Vieira
Pedro M Moraes-Vieira

11 June 2025 in Nature
Verified
Journal Article
Open access
PDF file
ZWZhaoquan Wang
Zhaoquan Wang
ALAllie Lipshutz
Allie Lipshutz
CTCelia Martínez de la Torre
Celia Martínez de la Torre
ATAlissa J. Trzeciak
Alissa J. Trzeciak
ZLZong-Lin Liu
Zong-Lin Liu
JPJustin S. A. Perry
Justin S. A. Perry
Despite the success of fructose as a low-cost food additive, epidemiological evidence suggests that high fructose consumption during pregnancy or adolescence is associated with disrupted neurodevelopment1,2,3. An essential step in appropriate mammalian neurodevelopment is the phagocytic elimination of newly formed neurons by microglia, the resident professional phagocyte of the central nervous system4. Whether high fructose consumption in early life affects microglial phagocytosis and whether this directly affects neurodevelopment remains unknown. Here we show that offspring born to female mice fed a high-fructose diet and neonates exposed to high fructose exhibit decreased phagocytic activity in vivo. Notably, deletion of the high-affinity fructose transporter GLUT5 (also known as SLC2A5) in neonatal microglia completely reversed microglia phagocytic dysfunction, suggesting that high fructose directly affects neonatal development by suppressing microglial phagocytosis. Mechanistically, we found that high-fructose treatment of mouse and human microglia suppresses phagocytosis capacity, which is rescued in GLUT5-deficient microglia. Additionally, we found that high fructose drives significant GLUT5-dependent fructose uptake and catabolism to fructose 6-phosphate, rewiring microglial metabolism towards a hypo-phagocytic state in part by enforcing mitochondrial localization of the enzyme hexokinase 2. Mice exposed to high fructose as neonates develop anxiety-like behaviour as adolescents—an effect that is rescued in GLUT5-deficient mice. Our findings provide a mechanistic explanation for the epidemiological observation that high-fructose exposure during early life is associated with increased prevalence of adolescent anxiety disorders.